EMMPRIN/CD147[FITC], His, Human

EMMPRIN/CD147[FITC], His, Human

CD147, also known as extracellular matrix metalloproteinase inducer (EMMPRIN) or basigin, is expressed in a variety of cell types. It is involved in the regulation of extracellular matrix (ECM) remodeling during physiological and pathological processes including wound healing, inflammatory diseases, and cancer. CD147 is a diagnostic and therapeutic target in cancer and inflammatory diseases, either directly or indirectly, by targeting CD147 partners.
Z04962
¥208,928.00

Ask us a question
Product Introduction
Species Human
Protein Construction
EMMPRIN/CD147 (Ala22-His205)
Accession # NP_940991.1		 His
N-term C-term
Conjugate [FITC]
Purity > 95% as determined by Bis­Tris PAGE
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Immobilized EMMPRIN/CD147[FITC], His, Human at 0.5μg/ml (100μl/well) on the plate can bind Anti­EMMPRIN Antibody, hFc Tag. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 21.2 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 28-40 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Background
Target Background CD147, also known as extracellular matrix metalloproteinase inducer (EMMPRIN) or basigin, is expressed in a variety of cell types. It is involved in the regulation of extracellular matrix (ECM) remodeling during physiological and pathological processes including wound healing, inflammatory diseases, and cancer. CD147 is a diagnostic and therapeutic target in cancer and inflammatory diseases, either directly or indirectly, by targeting CD147 partners.
Synonyms Basigin; BSG; CD147; 5F7; M6; OK; TCSF

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.